Trellis Bioscience 's CellSpot(TM) platform enables us to find rare human monoclonal antibodies. We apply the technology to develop therapies against cancer and infectious diseases, and find solutions when the immune system attacks protein therapeutics
Location: United States, California, Redwood City
Total raised: $10M
Investors 3
| Date | Name | Website |
| - | New Scienc... | newscience... |
| - | Easton Cap... | eastoncapi... |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 14.02.2007 | - | $10M | - | venturebea... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 22.07.2017 | CMC Biolog... | Development of Trellis’ monocl... | - | - | eeplp.com/... |
| 14.02.2007 | Trellis Bi... | Trellis Bioscience, a South Sa... | - | - | venturebea... |